Global Osteoarthritis Market to Hit $11.91 Billion by 2030 at 9.9% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Osteoarthritis Market Be By 2030 Compared To Its 2026 Market Size?

The osteoarthritis market has experienced substantial growth in recent years. Projections indicate a rise from $7.49 billion in 2025 to $8.16 billion in 2026, at a compound annual growth rate (CAGR) of 8.9%. This historical growth can be attributed to factors such as the increasing global prevalence of osteoarthritis, the limited availability of advanced joint therapies in earlier times, an expanding aging population suffering from joint degeneration, the initial adoption of conventional medications and surgeries, and a heightened awareness of joint health and pain management.

The osteoarthritis market size is anticipated to experience substantial growth over the coming years, projected to reach $11.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This expansion during the forecast period is fueled by several factors, including the increasing embrace of minimally invasive and robotic-assisted surgeries, greater utilization of biologics and DMOADs, the development of healthcare infrastructure for joint care, the growing adoption of digital diagnostics and AI-based monitoring, and enhanced patient awareness regarding lifestyle and weight management programs. Key trends expected in this period encompass the rising prevalence of minimally invasive joint replacement surgeries, increased application of biologic therapies and hyaluronic acid injections, a growing integration of digital imaging and AI-driven diagnostics, an intensifying focus on personalized osteoarthritis management strategies, and greater investment in physical therapy and rehabilitation initiatives.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

What Key Factors Are Shaping The Osteoarthritis Market Landscape?

The increasing prevalence of obesity-related disorders is anticipated to fuel the expansion of the osteoarthritis market moving forward. These conditions involve various health problems arising from excessive body fat, often caused by consuming more calories than expended through physical activity, a diet high in processed or fast food, and excessive alcohol consumption. Obesity can lead to osteoarthritis by stressing joints, causing inflammation, and modifying hormones, thus increasing the burden on the joints. For instance, in September 2024, figures from the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, showed that the number of states with an adult obesity prevalence of 35% or higher climbed from 22 states in 2022 to 23 states in 2023. This rise in obesity-related disorders is therefore propelling the growth of the osteoarthritis market.

Which Segment Classifications Are Used In The Osteoarthritis Market Segment Analysis?

The osteoarthritis market covered in this report is segmented –

1) By Treatment: Medication, Surgery, Therapy

2) By Diagnosis: Imaging, Joint Fluid Analysis

3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route

4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis

5) By End-User: Hospitals, Medical Institutes

Subsegments:

1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)

2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion

3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

What Market Trends Are Affecting The Osteoarthritis Market?

Leading firms within the osteoarthritis market are embracing strategic partnerships as a strategy to boost technology integration and broaden their market presence. Such partnerships typically involve a collaborative arrangement among two or more entities that pool their resources, knowledge, and efforts to accomplish shared aims or targets. An illustrative example is LG Chem, a South Korea-based pharmaceutical company, which penetrated the Chinese market in July 2024 by partnering with Yifan Pharmaceutical Co., Ltd., a China-based pharmaceutical research and production company. This collaboration was established to introduce Synovian injection for osteoarthritis, offering comparable therapeutic benefits to conventional multi-injection formulations through a single administration. Distinctive attributes of Synovian encompass its high molecular weight (10 million Dalton) hyaluronic acid, which improves viscoelasticity and joint function, alongside its proven capacity to substantially alleviate knee pain, as demonstrated by clinical phase 3 trial outcomes. Consequently, this innovation establishes Synovian as an efficacious choice for individuals seeking accessible relief from the symptoms of osteoarthritis.

Which Firms Are Contributing To The Osteoarthritis Market Ecosystem?

Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics plc, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

Get The Full Osteoarthritis Market Report:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Where Is The Osteoarthritis Market Most Concentrated Geographically?

North America was the largest region in the osteoarthritis market in 2025. The regions covered in the osteoarthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Osteoarthritis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

Browse Through More Reports Similar to the Global Osteoarthritis Market 2026, By The Business Research Company

Soft Tissue Repair Market Report 2026

https://www.thebusinessresearchcompany.com/report/soft-tissue-repair-global-market-report

Orthopedic Regenerative Surgical Products Market Report

https://www.thebusinessresearchcompany.com/report/orthopedic-regenerative-surgical-products-global-market-report

Cartilage Repair Market Report

https://www.thebusinessresearchcompany.com/report/cartilage-repair-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795